ZBED3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.894600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.944200E-01
Normal-vs-Stage2
2.910200E-01
Normal-vs-Stage3
1.905410E-01
Normal-vs-Stage4
6.633600E-01
Stage1-vs-Stage2
1.026190E-01
Stage1-vs-Stage3
3.735500E-02
Stage1-vs-Stage4
7.049200E-01
Stage2-vs-Stage3
1.353820E-01
Stage2-vs-Stage4
2.447600E-02
Stage3-vs-Stage4
3.268400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.012600E-01
Normal-vs-AfricanAmerican
8.615200E-01
Normal-vs-Asian
2.756600E-01
Caucasian-vs-AfricanAmerican
5.682000E-01
Caucasian-vs-Asian
2.682200E-01
AfricanAmerican-vs-Asian
2.538200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.997200E-01
Normal-vs-Female
6.087800E-01
Male-vs-Female
3.407800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.042000E-01
Normal-vs-Age(41-60Yrs)
6.017000E-01
Normal-vs-Age(61-80Yrs)
4.267600E-01
Normal-vs-Age(81-100Yrs)
1.866570E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.681400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.348800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.709000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.413600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.590800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.622200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.120600E-01
Normal-vs-Daily Drinker
4.537200E-01
Normal-vs-Weekly Drinker
5.847400E-01
Normal-vs-Occasional Drinker
4.148400E-01
Normal-vs-Social Drinker
9.020600E-01
Non Drinker-vs-Daily Drinker
5.384000E-01
Non Drinker-vs-Weekly Drinker
2.327600E-01
Non Drinker-vs-Occasional Drinker
4.576400E-01
Non Drinker-vs-Social Drinker
5.288100E-02
Daily Drinker-vs-Weekly Drinker
1.288770E-01
Daily Drinker-vs-Occasional Drinker
2.512000E-01
Daily Drinker-vs-Social Drinker
3.035800E-02
Weekly Drinker-vs-Occasional Drinker
6.895400E-01
Weekly Drinker-vs-Social Drinker
2.895200E-01
Occasional Drinker-vs-Social Drinker
1.334350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.413800E-01
Normal-vs-Grade 2
1.034180E-01
Normal-vs-Grade 3
5.958100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.160200E-01
Grade 1-vs-Grade 3
3.927400E-01
Grade 1-vs-Grade 4
2.413800E-01
Grade 2-vs-Grade 3
7.987800E-01
Grade 2-vs-Grade 4
1.034180E-01
Grade 3-vs-Grade 4
5.958100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.985000E-01
Normal-vs-NonDiabetic
4.688600E-01
Diabetic-vs-NonDiabetic
7.986200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.429000E-01
Normal-vs-NoPancreatitis
4.805000E-01
Pancreatitis-vs-NoPancreatitis
4.241400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.442600E-01
Normal-vs-N1
3.444800E-01
N0-vs-N1
6.020600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.176200E-01
Normal-vs-TP53-NonMutant
9.552000E-01
TP53-Mutant-vs-TP53-NonMutant
2.002800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
